Seeking Alpha

ALTH Transcripts Search Results

Results 1-7 for ptcl (out of 7)
Refine your search:

You can use: AND, NOT, OR, " " (exact phrase)

Search across all Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)


  • Allos Therapeutics, Inc., Q3 2009 Earnings Call Transcript 03 Nov, 2009
    ... based hematologist oncologists who treat PTCL overall response rate complete response ... patients with newly diagnosed aggressive PTCL who have responded following initial ... the US. We believe the PTCL market outside the US is ...
  • Allos Therapeutics, Inc. Q4 2008 Earnings Call Transcript 19 Mar, 2009
    ... 150 hematologists, oncologists who treat PTCL, response rate, duration of response, ... 6,000 new cases of PTCL per year. In addition, we ... studies ongoing in T-cell malignancies, PTCL in particular, the multi-center design, ...
  • Allos Therapeutics Inc. Q3 2008 Earnings Call Transcript 06 Nov, 2008
    ... for the treatment of patients with relapsed or refractory PTCL as expeditiously as possible. In addition to PROPEL ... to the medical literature, patients with aggressive PTCL have an overall five-year survival rate of ...
  • Allos Therapeutics, Inc. Q2 2008 Earnings Call Transcript 08 Sep, 2008
    ... patients with relapsed or refractory PTCL as expeditiously as possible. Now ... agency agreed that even though PTCL comprise heterogeneous group of diseases. ... discussion around both the CTCL, PTCL and B-cell was mentioned. And ...
  • Allos Therapeutics Inc. Q1 2008 Earnings Call Transcript 26 May, 2008
    ... patients with relapsed or refractory PTCL, a first-to-market opportunity for Allos. ... for our initial indication for PTCL, that first-to-market opportunity, we think ... MSK usually uses with their PTCL patients? I mean I know ...
  • Allos Therapeutics, Inc Q4 2007 Earnings Call Transcript 17 Apr, 2008
    ... for the treatment of patients with PTCL from the Commission of the European ... makes our space in the PTCL area in particular highly scalable. So ... question regarding pralatrexate progress in PTCL trial. Can you run through ...
  • Allos Therapeutics Q3 2007 Earnings Call Transcript 05 Nov, 2007
    ... patients with relapsed or refractory PTCL will be enrolled with the ... down stream in hemalignancies in particular PTCL, right now there are no ... a function of increasing awareness of PTCL and physicians’ ability to deal ...
Search ALTH Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)

Most Popular Searches

in ALTH transcripts

Other Transcripts
from the Healthcare Sector
  1. Prospect Medical Holdings Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
  2. Hansen Medical, Inc. Q3 2009 Earnings Call Transcript
  3. Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
To search across transcripts, find the most recent and most popular and view by sector, try: Seeking Alpha's Transcript Center